# Rezum for 30-80ml Patients With Moderate-severe LUTS to Study Surgical Principles for Median Lobe Enlargement

> **NCT06177821** · NA · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 44 (estimated)

## Conditions studied

- Prostatic Hyperplasia of the Medial Lobe

## Interventions

- **DEVICE:** Rezum®

## Key facts

- **NCT ID:** NCT06177821
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-06-03
- **Primary completion:** 2024-06-17
- **Final completion:** 2025-12-30
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2024-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06177821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06177821, "Rezum for 30-80ml Patients With Moderate-severe LUTS to Study Surgical Principles for Median Lobe Enlargement". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06177821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*